Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension

Molecular and Cellular Biochemistry

Volumn 373, Issue 1-2, 2013, Pages 161-170

  Enache, Irina ^a,b   Charles, Anne Laure ^a,b   Bouitbir, Jamal ^a,b   Favret, Fabrice ^b   Zoll, Joffrey ^a,b   Metzger, Daniel ^c   Oswald Mammosser, Monique ^a,b   Geny, Bernard ^a,b   Charloux, Anne ^a,b  

^a HÔPITAL CIVIL   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Mitochondria; Monocrotaline; PGC 1 ; Pulmonary hypertension; Right ventricular failure

Indexed keywords

CITRATE SYNTHASE; MESSENGER RNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MONOCROTALINE; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CELL RESPIRATION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; MALE; MITOCHONDRION; NONHUMAN; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; SKELETAL MUSCLE;

ANIMALS; CITRATE (SI)-SYNTHASE; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLES; HYPERTENSION, PULMONARY; MALE; MITOCHONDRIA, MUSCLE; MONOCROTALINE; MUSCLE, SKELETAL; NUCLEAR RESPIRATORY FACTOR 1; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; RNA-BINDING PROTEINS; SIRTUIN 1; TRANSCRIPTION FACTORS; VENTRICULAR DYSFUNCTION, RIGHT;

RATTUS;

EID: 84871748314     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1485-6     Document Type: Article

References (55)

1. Chin KM, Kim NH, Rubin LJ (2005) The right ventricle in pulmonary hypertension. Coron Artery Dis 16(1):13-18
2. Sharov VG, Todor AV, Silverman N et al (2000) Abnormal mitochondrial respiration in failed human myocardium. J Mol Cell Cardiol 32(12):2361-2367
3. De Sousa E, Lechene P, Fortin D et al (2002) Cardiac and skeletal muscle energy metabolism in heart failure: beneficial effects of voluntary activity. Cardiovasc Res 56(2):260-268
4. Zoll J, Monassier L, Garnier A et al (2006) ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction. J Appl Physiol 101(2):385-391
5. Mettauer B, Zoll J, Garnier A et al (2006) Heart failure: a model of cardiac and skeletal muscle energetic failure. Pflugers Arch 452(6):653-666
6. Rimbaud S, Garnier A, Ventura-Clapier R (2009) Mitochondrial biogenesis in cardiac pathophysiology. Pharmacol Rep 61(1):131-138
7. Garnier A, Fortin D, Delomenie C et al (2003) Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 551(Pt 2):491-501
8. Mudd JO, Kass DA (2008) Tackling heart failure in the twenty-first century. Nature 451(7181):919-928
9. Bogaard HJ, Abe K, Vonk Noordegraaf A et al (2009) The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 135(3):794-804
10. Daicho T, Yagi T, Abe Y et al (2009) Possible involvement of mitochondrial energy-producing ability in the development of right ventricular failure in monocrotaline-induced pulmonary hypertensive rats. J Pharmacol Sci 111(1):33-43
11. Buermans HP, Redout EM, Schiel AE et al (2005) Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Physiol Genomics 21(3):314-323
12. Lourenco AP, Roncon-Albuquerque R Jr, Bras-Silva C et al (2006) Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 291(4):H1587-H1594
13. Correia-Pinto J, Henriques-Coelho T, Roncon-Albuquerque R Jr et al (2009) Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension. Basic Res Cardiol 104(5):535-545
14. Usui S, Yao A, Hatano M et al (2006) Upregulated neurohumoral factors are associated with left ventricular remodeling and poor prognosis in rats with monocrotaline-induced pulmonary arterial hypertension. Circ J 70(9):1208-1215
15. Bauer R, Dehnert C, Schoene P et al (2007) Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med 101(11):2366-2369
16. Meyer FJ, Lossnitzer D, Kristen AV et al (2005) Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J 25(1):125-130
17. Tolle J, Waxman A, Systrom D (2008) Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension. Med Sci Sports Exerc 40(1):3-8
18. Wust RC, Myers DS, Stones R et al (2012) Regional skeletal muscle remodeling and mitochondrial dysfunction in right ventricular heart failure. Am J Physiol Heart Circ Physiol 302(2):H402-H411
19. Mainguy V, Maltais F, Saey D et al (2010) Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax 65(2):113-117
20. Vescovo G, Ceconi C, Bernocchi P et al (1998) Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy. Cardiovasc Res 39(1):233-241
21. Vescovo G, Zennaro R, Sandri M et al (1998) Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. J Mol Cell Cardiol 30(11):2449-2459
22. Bernocchi P, Cargnoni A, Vescovo G et al (2003) Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure. Basic Res Cardiol 98(2):114-123
23. Sullivan MJ, Higginbotham MB, Cobb FR (1988) Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation 78(3):506-515
24. van Ranst D, Otten H, Meijer JW et al (2011) Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status. Int J Chron Obstruct Pulmon Dis 6647-6657
25. Altenburg WA, de Greef MH, ten Hacken NH et al (2012) A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients. Respir Med 106(5):694-700
26. Daussin FN, Zoll J, Dufour SP et al (2008) Effect of interval versus continuous training on cardiorespiratory and mitochondrial functions: relationship to aerobic performance improvements in sedentary subjects. Am J Physiol Regul Integr Comp Physiol 295(1):R264-R272
27. Gaine SP, Rubin LJ (1998) Primary pulmonary hypertension. Lancet 352(9129):719-725
28. Fox BD, Kassirer M, Weiss I et al (2011) Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. J Card Fail 17(3):196-200
29. Grunig E, Ehlken N, Ghofrani A et al (2012) Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration 81(5):394-401
30. Hardziyenka M, Campian ME, de Bruin-Bon HA et al (2006) Sequence of echocardiographic changes during development of right ventricular failure in rat. J Am Soc Echocardiogr 19(10):1272-1279
31. Campian ME, Hardziyenka M, Michel MC et al (2006) How valid are animal models to evaluate treatments for pulmonary hypertension? Naunyn Schmiedebergs Arch Pharmacol 373(6):391-400
32. Urboniene D, Haber I, Fang YH et al (2010) Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 299(3):L401-L412
33. Jones JE, Mendes L, Rudd MA et al (2002) Serial noninvasive assessment of progressive pulmonary hypertension in a rat model. Am J Physiol Heart Circ Physiol 283(1):H364-H371
34. Hessel MH, Steendijk P, den Adel B et al (2006) Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat. Am J Physiol Heart Circ Physiol 291(5):H2424-H2430
35. Dalla Libera L, Ravara B, Volterrani M et al (2004) Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure. Am J Physiol Cell Physiol 286(1):C138-C144
36. Kitzman DW, Scholz DG, Hagen PT et al (1988) Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc 63(2):137-146
37. Scholz DG, Kitzman DW, Hagen PT et al (1988) Age-related changes in normal human hearts during the first 10 decades of life. Part I (Growth): A quantitative anatomic study of 200 specimens from subjects from birth to 19 years old. Mayo Clin Proc 63(2):126-136
38. Liu W, Saint DA (2002) A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal Biochem 302(1):52-59
39. Ramakers C, Ruijter JM, Deprez RH et al (2003) Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339(1):62-66
40. Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127(6):1109-1122
41. Wust RC, Jaspers RT, van Heijst AF et al (2009) Region-specific adaptations in determinants of rat skeletal muscle oxygenation to chronic hypoxia. Am J Physiol Heart Circ Physiol 297(1):H364-H374
42. Bouitbir J, Charles AL, Echaniz-Laguna A et al (2011) Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1. Eur Heart J
43. Estep JE, Lame MW, Morin D et al (1991) [14C]monocrotaline kinetics and metabolism in the rat. Drug Metab Dispos 19(1):135-139
44. Vescovo G, Ravara B, Gobbo V et al (2005) Skeletal muscle fibres synthesis in heart failure: role of PGC-1alpha, calcineurin and GH. Int J Cardiol 104(3):298-306
45. Puigserver P, Spiegelman BM (2003) Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24(1):78-90
46. Puigserver P, Rhee J, Lin J et al (2001) Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell 8(5):971-982
47. Mettauer B, Zoll J, Sanchez H et al (2001) Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol 38(4):947-954
48. Rehn TA, Munkvik M, Lunde PK et al (2012) Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning? Heart Fail Rev 17(3):421-436
49. Pette D, Staron RS (2001) Transitions of muscle fiber phenotypic profiles. Histochem Cell Biol 115(5):359-372
50. Picard M, Hepple RT, Burelle Y (2012) Mitochondrial functional specialization in glycolytic and oxidative muscle fibers: tailoring the organelle for optimal function. Am J Physiol Cell Physiol 302(4):C629-C641
51. Karamanlidis G, Nascimben L, Couper GS et al (2010) Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res 106(9):1541-1548
52. Akhavein F, St-Michel EJ, Seifert E et al (2007) Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats. J Appl Physiol 103(1):287-295
53. Schott P, Singer SS, Kogler H et al (2005) Pressure overload and neurohumoral activation differentially affect the myocardial proteome. Proteomics 5(5):1372-1381
54. Blomstrand E, Radegran G, Saltin B (1997) Maximum rate of oxygen uptake by human skeletal muscle in relation to maximal activities of enzymes in the Krebs cycle. J Physiol 501(Pt 2):455-460
55. Redout EM, Wagner MJ, Zuidwijk MJ et al (2007) Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species. Cardiovasc Res 75(4):770-781